Browsing byAuthorEldehna, WM

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2023-04-041-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights.Al-Warhi, T; Almahli, H; Maklad, RM; Elsayed, ZM; El Hassab, MA; Alotaibi, OJ; Aljaeed, N; Ayyad, RR; Ghabour, HA; Eldehna, WM; El-Ashrey, MK
2024-12Design, synthesis, and in silico insights of novel N'-(2-oxoindolin-3-ylidene)piperidine-4-carbohydrazide derivatives as VEGFR-2 inhibitors.Eldehna, WM; Habib, YA; Mahmoud, AE; Barghash, MF; Elsayed, ZM; Elsawi, AE; Maklad, RM; Rashed, M; Khalil, A; Hammad, SF; Ali, MM; El Kerdawy, AM
2021-12Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.Al-Sanea, MM; Al-Ansary, GH; Elsayed, ZM; Maklad, RM; Elkaeed, EB; Abdelgawad, MA; Bukhari, SNA; Abdel-Aziz, MM; Suliman, H; Eldehna, WM
2022-10-27Development of novel isatin thiazolyl-pyrazoline hybrids as promising antimicrobials in MDR pathogens.Al-Warhi, T; Elimam, DM; Elsayed, ZM; Abdel-Aziz, MM; Maklad, RM; Al-Karmalawy, AA; Afarinkia, K; Abourehab, MAS; Abdel-Aziz, HA; Eldehna, WM
2022-12Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights.Eldehna, WM; Maklad, RM; Almahli, H; Al-Warhi, T; Elkaeed, EB; Abourehab, MAS; Abdel-Aziz, HA; El Kerdawy, AM
2023-09-05Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation.Ibrahim, TM; Abada, G; Dammann, M; Maklad, RM; Eldehna, WM; Salem, R; Abdelaziz, MM; El-Domany, RA; Bekhit, AA; Beockler, FM